Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Serum levels of pentosidine in patients on bisphosphonate therapy with and without atypical femoral fractures.

FY 2015-16

Summary
Atypical femoral fractures (AFFs) are of significant concern following long-term bisphosphonate use as they can lead to significant morbidity. Putative mechanisms in AFF pathogenesis include changes in normal collagen cross-linking and accumulation of advanced glycation end-products (AGEs). No study to our knowledge has examined serum pentosidine levels in the AFF population. The primary objective of the study is to examine serum pentosidine levels between patients on bisphosphonate therapy with and without atypical femoral fractures. Participants have been selected from the Ontario Atypical Fracture Cohort Study. Demographic and clinical data have been collected as part of the cohort study. Given that commercially available assays measuring serum pentosidine have high coefficients of variation, we will develop a new method as the initial phase of the study. Assessing serum pentosidine levels in patients with AFFs is a step towards recognizing potential markers to assess bone quality to screen for AFFs.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
349919
Name
Wong Evelyn M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Serum levels of pentosidine in patients on bisphosphonate therapy with and without atypical femoral fractures.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Atypical Femoral Fractures; Long-Term Bisphosphonate; Pentosidine
Abstract
Atypical femoral fractures (AFFs) are of significant concern following long-term bisphosphonate use as they can lead to significant morbidity. Putative mechanisms in AFF pathogenesis include changes in normal collagen cross-linking and accumulation of advanced glycation end-products (AGEs). No study to our knowledge has examined serum pentosidine levels in the AFF population. The primary objective of the study is to examine serum pentosidine levels between patients on bisphosphonate therapy with and without atypical femoral fractures. Participants have been selected from the Ontario Atypical Fracture Cohort Study. Demographic and clinical data have been collected as part of the cohort study. Given that commercially available assays measuring serum pentosidine have high coefficients of variation, we will develop a new method as the initial phase of the study. Assessing serum pentosidine levels in patients with AFFs is a step towards recognizing potential markers to assess bone quality to screen for AFFs.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wong, Evelyn M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~